Sales of Prevnar, made by the pharmaceutical giant Wyeth, soared 32 percent in the third quarter to $321 million, the Chicago Tribune said Thursday.
A recent financial statement indicated this came about in part because the company made upgrades and improvements to its manufacturing facilities over the last year.
Prevnar vaccine costs about $260 for the four-shot regimen given to infants and young children. A dose of flu vaccine, by contrast, fetches about $8.
Wyeth left the flu vaccine market entirely last year to focus resources on its more lucrative vaccine.
Susan Sarandon 'very excited' about daughter's pregnancy
Teacher apologizes for showing sexual image of herself in class